Published in Drugs on January 01, 2007
Neuroprotection in glaucoma: drug-based approaches. Optom Vis Sci (2008) 1.04
Quantification of deficits in spatial visual function of mouse models for glaucoma. Invest Ophthalmol Vis Sci (2011) 0.97
Glaucomatous optic neuropathy management: the role of neuroprotective agents. Med Hypothesis Discov Innov Ophthalmol (2013) 0.95
17β-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma. Mol Pharm (2013) 0.91
Neuroprotection in glaucoma. Indian J Ophthalmol (2011) 0.88
The role of peroxisome proliferator-activated receptor and effects of its agonist, pioglitazone, on a rat model of optic nerve crush: PPARγ in retinal neuroprotection. PLoS One (2013) 0.86
Involvement of transcription initiation factor IIB in the light-induced death of rat retinal ganglion cells in vivo. J Mol Histol (2012) 0.86
Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine. Clin Ophthalmol (2011) 0.84
A novel high-content flow cytometric method for assessing the viability and damage of rat retinal ganglion cells. PLoS One (2012) 0.83
Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-α-induced damage. PLoS One (2013) 0.82
Psychophysical testing in rodent models of glaucomatous optic neuropathy. Exp Eye Res (2015) 0.76
Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma. Neural Regen Res (2012) 0.76
Expression of RBMX in the light-induced damage of rat retina in vivo. Cell Mol Neurobiol (2014) 0.76
Pharmacological neuroprotection for glaucoma. Drugs (2007) 0.75
Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma. Med Hypothesis Discov Innov Ophthalmol (2015) 0.75
Ocular expression and distribution of products of the POAG-associated chromosome 9p21 gene region. PLoS One (2013) 0.75
Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res (2004) 3.08
Does anybody care that the crystalline lens never gets cancer? Clin Experiment Ophthalmol (2013) 2.53
Recharacterization of the RGC-5 retinal ganglion cell line. Invest Ophthalmol Vis Sci (2009) 1.74
Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma. Arch Ophthalmol (2011) 1.47
Central corneal thickness among Aboriginal people attending eye clinics in remote South Australia. Clin Experiment Ophthalmol (2007) 1.45
Definition of glaucoma: clinical and experimental concepts. Clin Experiment Ophthalmol (2012) 1.43
The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol (2011) 1.29
Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci (2010) 1.14
Australian and New Zealand Registry of Advanced Glaucoma: methodology and recruitment. Clin Experiment Ophthalmol (2012) 1.09
Homozygous mutations in PXDN cause congenital cataract, corneal opacity, and developmental glaucoma. Am J Hum Genet (2011) 1.08
A comparison of differentiation protocols for RGC-5 cells. Invest Ophthalmol Vis Sci (2010) 1.07
Cataract in central Sri Lanka: cataract surgical coverage and self-reported barriers to cataract surgery. Clin Experiment Ophthalmol (2009) 1.04
Association between stature, ocular biometry and refraction in an adult population in rural Myanmar: the Meiktila eye study. Clin Experiment Ophthalmol (2007) 1.01
The prevalence and causes of visual impairment in central Sri Lanka the Kandy Eye study. Ophthalmology (2008) 0.99
Prevalence and causes of visual impairment in a Brazilian population: the Botucatu Eye Study. BMC Ophthalmol (2009) 0.96
Ophthalmologists' success in cancer prevention: response. Clin Experiment Ophthalmol (2013) 0.96
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON). Neurobiol Dis (2006) 0.95
Translational neuroprotection research in glaucoma: a review of definitions and principles. Clin Experiment Ophthalmol (2011) 0.94
Interleukin-6 is an efficacious marker of axonal transport disruption during experimental glaucoma and stimulates neuritogenesis in cultured retinal ganglion cells. Neurobiol Dis (2012) 0.94
Cataract surgical coverage and self-reported barriers to cataract surgery in a rural Myanmar population. Clin Experiment Ophthalmol (2008) 0.94
Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries. Invest Ophthalmol Vis Sci (2008) 0.92
Estimation of axon counts in a rat model of glaucoma: comparison of fixed-pattern sampling with targeted sampling. Clin Experiment Ophthalmol (2012) 0.92
Association of genetic variants in the TMCO1 gene with clinical parameters related to glaucoma and characterization of the protein in the eye. Invest Ophthalmol Vis Sci (2012) 0.91
Ophthalmic and adnexal complications of radiotherapy. Acta Ophthalmol Scand (2007) 0.90
Association between erythropoietin gene polymorphisms and diabetic retinopathy. Arch Ophthalmol (2010) 0.90
Glaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucoma. Ophthalmology (2012) 0.90
Invited review: Neuroprotective properties of certain beta-adrenoceptor antagonists used for the treatment of glaucoma. J Ocul Pharmacol Ther (2005) 0.90
Expression of monocarboxylate transporters in rat ocular tissues. Am J Physiol Cell Physiol (2004) 0.90
Exophthalmometric values and their biometric correlates: The Kandy Eye Study. Clin Experiment Ophthalmol (2009) 0.88
Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study. BMC Neurosci (2010) 0.88
Evaluation of Fluoro-Jade C as a marker of degenerating neurons in the rat retina and optic nerve. Exp Eye Res (2008) 0.86
Tarsal height. Ophthalmology (2009) 0.85
The effect of hyperglycemia on hypoperfusion-induced injury. Invest Ophthalmol Vis Sci (2009) 0.84
Metipranolol blunts nitric oxide-induced lipid peroxidation and death of retinal photoreceptors: a comparison with other anti-glaucoma drugs. Invest Ophthalmol Vis Sci (2004) 0.84
Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat. Invest Ophthalmol Vis Sci (2009) 0.83
Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity. Invest Ophthalmol Vis Sci (2002) 0.83
Localization of a wide-ranging panel of antigens in the rat retina by immunohistochemistry: comparison of Davidson's solution and formalin as fixatives. J Histochem Cytochem (2011) 0.83
The effect of ischemic preconditioning on light-induced photoreceptor injury. Invest Ophthalmol Vis Sci (2003) 0.82
Distance refractive error among Aboriginal people attending eye clinics in remote South Australia. Clin Experiment Ophthalmol (2007) 0.82
Ethmoidal pneumocele following drainage of an ethmoidal mucocele. Orbit (2008) 0.81
Monocarboxylate transporter expression remains unchanged during the development of diabetic retinal neuropathy in the rat. Invest Ophthalmol Vis Sci (2005) 0.81
Mechanisms of neuroprotection by glucose in rat retinal cell cultures subjected to respiratory inhibition. Invest Ophthalmol Vis Sci (2013) 0.81
Killing two birds with one stone: the potential effect of cataract surgery on the incidence of primary angle-closure glaucoma in a high-risk population. Clin Experiment Ophthalmol (2011) 0.81
The beta-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis. Invest Ophthalmol Vis Sci (2006) 0.80
Age-related change in contrast sensitivity among Australian male adults: Florey Adult Male Ageing Study. Acta Ophthalmol (2012) 0.80
Visible light affects mitochondrial function and induces neuronal death in retinal cell cultures. Vision Res (2007) 0.80
The effect of retinal ganglion cell injury on light-induced photoreceptor degeneration. Invest Ophthalmol Vis Sci (2004) 0.80
Rapid and delayed death of cultured trabecular meshwork cells after selective laser trabeculoplasty. Lasers Surg Med (2010) 0.80
An explanation for the Warburg effect in the adult mammalian retina. Clin Experiment Ophthalmol (2013) 0.79
The mechanism of axonal degeneration after perikaryal excitotoxic injury to the retina. Exp Neurol (2012) 0.79
Changing barriers to use of eye care services in Timor-Leste: 2005 to 2010. Ophthalmic Epidemiol (2013) 0.79
Chromosome 9p21 primary open-angle glaucoma susceptibility locus: a review. Clin Experiment Ophthalmol (2013) 0.79
Bioenergetic-based neuroprotection and glaucoma. Clin Experiment Ophthalmol (2008) 0.79
Retinal damage profiles and neuronal effects of laser treatment: comparison of a conventional photocoagulator and a novel 3-nanosecond pulse laser. Invest Ophthalmol Vis Sci (2013) 0.79
Beta-adrenergic receptor agonists and antagonists counteract LPS-induced neuronal death in retinal cultures by different mechanisms. Brain Res (2003) 0.79
Prevalence of trachoma-related trichiasis and corneal opacity in rural Myanmar: the Meiktila Eye Study. Ophthalmology (2007) 0.78
Glial cell and inflammatory responses to retinal laser treatment: comparison of a conventional photocoagulator and a novel, 3-nanosecond pulse laser. Invest Ophthalmol Vis Sci (2013) 0.78
Prevalence of and risk factors for primary open-angle glaucoma in central Sri Lanka: the Kandy eye study. Ophthalmic Epidemiol (2010) 0.78
Prevalence of refractive errors in a Brazilian population: the Botucatu eye study. Ophthalmic Epidemiol (2009) 0.78
Quantum biology of the retina. Clin Experiment Ophthalmol (2014) 0.77
Intermediate-Term Cataract Surgery Outcomes from Rural Provinces in Lao People's Democratic Republic. Ophthalmic Epidemiol (2015) 0.77
Mitochondrial inhibition in rat retinal cell cultures as a model of metabolic compromise: mechanisms of injury and neuroprotection. Invest Ophthalmol Vis Sci (2012) 0.76
Nanosecond pulse lasers for retinal applications. Lasers Surg Med (2011) 0.76
The monocarboxylate transport inhibitor, alpha-cyano-4-hydroxycinnamate, has no effect on retinal ischemia. Brain Res (2003) 0.76
Angle closure and the lens. Clin Experiment Ophthalmol (2011) 0.75
Cataract surgery outcomes in the developing world. Clin Experiment Ophthalmol (2011) 0.75
Refractory glaucoma--here there be dragons. Clin Experiment Ophthalmol (2006) 0.75
Pathogenesis of retinal ganglion cell death in Leber hereditary optic neuropathy (LHON): possible involvement of mitochondria, light and glutamate. Mitochondrion (2006) 0.75
Ocular expression and distribution of products of the POAG-associated chromosome 9p21 gene region. PLoS One (2013) 0.75
Pathogenesis of primary open-angle glaucoma. Clin Experiment Ophthalmol (2012) 0.75
Immune priming and experimental glaucoma: the effect of prior systemic lipopolysaccharide challenge on tissue outcomes after optic nerve injury. Clin Experiment Ophthalmol (2014) 0.75
Potential adverse effects to the retina of cancer therapy targeting pyruvate kinase M2. Acta Oncol (2014) 0.75
Nerve Fiber Layer Infarcts in Thiamine Deficiency. J Neuroophthalmol (2015) 0.75
Ophthalmic research in Australasia. Clin Experiment Ophthalmol (2012) 0.75
Pharmaceutical advertising in ophthalmology. Clin Experiment Ophthalmol (2011) 0.75
Scientific information, journal impact factors and editorial policy. Clin Experiment Ophthalmol (2010) 0.75
Visual Acuity, Quality of Life and Visual Function Outcomes after Cataract Surgery in Bali. Ophthalmic Epidemiol (2015) 0.75
Prevalence of trachoma among a group of Aboriginal school children in remote South Australia. Clin Experiment Ophthalmol (2006) 0.75
Bilateral sixth nerve palsy. Ophthalmology (2006) 0.75
Evidence Supporting an Association Between Expression of Major Histocompatibility Complex II by Microglia and Optic Nerve Degeneration During Experimental Glaucoma. J Glaucoma (2016) 0.75
The pesty P value. Clin Experiment Ophthalmol (2011) 0.75